Presentation TCT 2015 The Real-World Practice of Surgery in Primary and Secondary MR: European Insights Presenter: Michael J. Mack, Patrick M. McCarthy, Ruediger Lange October 11, 2015
Presentation TCT 2015 Update on Medtronics Spyral Global Presenter: Farrell O. Mendelsohn, William B. White, Michael Böhm October 11, 2015
Presentation TCT 2015 The Real-World Practice of Surgery in Primary and Secondary MR: Outcomes in the Medicare Population Presenter: Michael J. Mack, Patrick M. McCarthy, Christina Vassileva October 11, 2015
Presentation TCT 2015 Acute and Late Results After Surgical Repair and Replacement of Degenerative MR Presenter: Michael J. Mack, Patrick M. McCarthy, James S. Gammie October 11, 2015
Presentation TCT 2015 How Good Can Surgical Outcomes Be in Secondary MR? The Expert Surgeons Perspective Presenter: Michael J. Mack, Patrick M. McCarthy October 11, 2015
Presentation TCT 2015 How Good Can Surgical Outcomes Be in Primary MR? The Expert Surgeons Perspective Presenter: Michael J. Mack, Patrick M. McCarthy, David H. Adams October 11, 2015
Presentation TCT 2015 Influence of Arterial Microanatomy on Response to Renal Artery Catheter Energy Denervation Presenter: Juan F. Granada, Michael Joner, Elazer R. Edelman October 11, 2015
Presentation TCT 2015 Debate 2: Should Long-term (2 Years to Life) Dual Antiplatelet Therapy Be Used in Most Patients After MI? Yes, and Vorapaxar Should Be Considered! Presenter: C. Michael Gibson, Marco Valgimigli, Ori Ben-Yehuda October 11, 2015
Presentation TCT 2015 KEYNOTE LECTURE: Redefining Aortic Stenosis Use of Advanced Imaging, Hemodynamics, Computational Models, and Clinical Data to Revise Trigger Points for Treatment Presenter: Eberhard Grube, Michael J. Mack, Elazer R. Edelman October 11, 2015
Presentation TCT 2015 Procedural Parameters for Successful Renal Denervation: Anything on the Horizon? Presenter: Juan F. Granada, Michael Joner, Michael Böhm October 11, 2015
Presentation TCT 2015 Debate 1: Should Cangrelor or an Oral ADP Antagonist Be Used in Most STEMI Patients? Prasugrel for Primary PCI Is Simplest and Best! Presenter: C. Michael Gibson, Marco Valgimigli, Sigmund Silber October 11, 2015
Presentation TCT 2015 Debate 1: Should Cangrelor or an Oral ADP Antagonist Be Used in Most STEMI Patients? Oral or Crushed Ticagrelor for All! Presenter: C. Michael Gibson, Marco Valgimigli, Guido Parodi October 11, 2015
Presentation TCT 2015 Evolving Endovascular Treatment Strategies for Femoral-Popliteal Disease in a DES and DCB World Presenter: Gary M. Ansel, Michael R. Jaff October 11, 2015
Presentation TCT 2015 Nerve Distribution Along the Renal Arteries: From the Branches to the Ostium Presenter: Juan F. Granada, Michael Joner October 11, 2015
Presentation TCT 2015 Debate 1: Should Cangrelor or an Oral ADP Antagonist Be Used in Most STEMI Patients? The Mechanism and Data Support Cangrelor! Presenter: C. Michael Gibson, Marco Valgimigli, Harvey D. White October 11, 2015
Presentation TCT 2015 Review and Perspectives of the Global Registry Data for Antiproliferative Therapies Presenter: Gary M. Ansel, Michael R. Jaff, John R. Laird Jr October 11, 2015
Presentation TCT 2015 Review of Multicenter, Randomized Outcomes Data of Antiproliferative Therapies: Zilver PTX, LEVANT II, In.PACT SFA, and DEFINITIVE AR Presenter: Gary M. Ansel, Michael R. Jaff, Ravish Sachar October 11, 2015
Presentation TCT 2015 Surgical LAA Closure: Patient Selection and Supporting Data Presenter: David R. Holmes Jr., Vivek Y. Reddy, Michael Argenziano October 11, 2015
Presentation TCT 2015 Debate: Fate of the Multidisciplinary Heart Valve Team as TAVR Becomes a TF-First Minimalist Procedure Inevitable Decline! Presenter: Eberhard Grube, Michael J. Mack, Ganesh Manoharan October 11, 2015
Presentation TCT 2015 Peering Through the Veil: Outcomes Reporting in SFA Intervention Decoded Presenter: Gary M. Ansel, Michael R. Jaff, William A. Gray October 11, 2015